Sci Rep 12:2890 Malesevic M, Strijowski U, Bchle D, Sewald N (2004) An improved method for the solution cyclization of peptides under pseudo-high dilution conditions
Furthermore, GLP-1 RAs have demonstrated significant reductions in major adverse cardiovascular events (MACE), heart failure hospitalizations, and all-cause mortality in patients with T2DM, and obesity, benefits not consistently observed with CPAP in randomized cardiovascular outcome trials [2527]
doi: 10.1016/j.numecd.2020.05.031 41 ShahAACraigDMSebekJKHaynesCStevensRCMuehlbauerMJet al
doi: 10.1128/IAI.71.7.4163-4166.2003 169 HafsiNVolandPSchwendySRadRReindlWGerhardMet al
Table 1 provides an overview of representative clinical trials testing MGBA-targeted interventions in neurodegenerative diseases
Mar 2021;19(3):473-483 e17